Douglas Earl Martin
Allogene Therapeutics, Inc. · SVP
Douglas Earl Martin is listed in public filings as officer: SVP, General Counsel. This Douglas Earl Martin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Allogene Therapeutics, Inc. (ALLO). Investors use Douglas Earl Martin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.0M539.1k shares | Grant / ExerciseFeb 2, 2026 | $1.0M539.1k shares | $1.87 | -- | |
| --152.5k shares | Grant / ExerciseFeb 2, 2026 | Disclosure amount unavailable152.5k shares | -- | -- | |
| $994k564.9k shares | SellFeb 2, 2026 | $40.3K22.9k shares | $1.76 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.0M587.8k shares | SellFeb 3, 2025 | $11.0K6.4k shares | $1.71 | -- | |
| $994k512.4k shares | Grant / ExerciseJan 24, 2025 | $994.0K512.4k shares | $1.94 | -- | |
| --594.3k shares | Grant / ExerciseJan 24, 2025 | Disclosure amount unavailable144.9k shares | -- | -- | |
| $1.3M449.3k shares | Grant / ExerciseAug 21, 2024 | $78.8K28.3k shares | $2.79 | -- |